Cohort profile: National Diabetes Audit for England and Wales.
Adolescent
Adult
Aged
Aged, 80 and over
Blood Pressure
COVID-19
/ epidemiology
Child
Child, Preschool
Clinical Audit
Cohort Studies
Comorbidity
Diabetes Mellitus, Type 1
/ epidemiology
Diabetes Mellitus, Type 2
/ epidemiology
England
/ epidemiology
Female
Follow-Up Studies
Glycated Hemoglobin
/ analysis
Humans
Hypoglycemic Agents
/ therapeutic use
Infant
Male
Middle Aged
Quality of Health Care
SARS-CoV-2
Treatment Outcome
Wales
/ epidemiology
Young Adult
audit
cohort
dataset
diabetes
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
19
03
2021
accepted:
28
05
2021
pubmed:
2
6
2021
medline:
26
8
2021
entrez:
1
6
2021
Statut:
ppublish
Résumé
The National Diabetes Audit (NDA) collates and analyses data on the quality and variation in clinical care and outcomes for people with diabetes. It also provides opportunities to assess trends, determinants, and outcomes of diabetes to help guide clinical and public health priorities. Between 1 January 2003 and 31 March 2020, a total of 5,280,885 people diagnosed with diabetes were included in at least one NDA data collection. To this date, median follow-up was 12 and 8 years for people with type 1 diabetes and type 2 diabetes respectively. Comparisons with the 2019/20 Quality and Outcomes Framework show it included 98% of adults in England and Wales with diagnosed type 1 and type 2 diabetes. Data include demographic characteristics (age, sex, ethnicity, age at diagnosis, deprivation), risk factors (HbA Secondary analyses have included comparisons of HbA Commissioned NDA reports will continue to inform service development in England and Wales. The same data, with or without linkages to other external datasets, are also a rich resource for clinically orientated research.
Substances chimiques
Glycated Hemoglobin A
0
Hypoglycemic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14616Subventions
Organisme : NHS England
Organisme : Diabetes UK
Pays : United Kingdom
Informations de copyright
© 2021 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
Références
NICE. Type 1 diabetes in adults: diagnosis and management, NICE guideline [NG17]. https://www.nice.org.uk/guidance/ng17. Published 2016. Accessed 8 December 2020.
NICE. Type 2 diabetes in adults: management, NICE guideline [NG28]. https://www.nice.org.uk/guidance/ng28. Published 2019. Accessed 8 December 2020.
NHS Digital. National Data Opt-Out. NHS Digital. https://digital.nhs.uk/services/national-data-opt-out. Published 2020; Accessed 12 December 2020.
NHS Digital. National Data Opt-out, June 2020. NHS Digital. https://digital.nhs.uk/data-and-information/publications/statistical/national-data-opt-out/june-2020. Published 2020. Accessed 13 December 2020.
NHS Digital. How the national data opt-out affects data released by NHS Digital. https://digital.nhs.uk/services/data-access-request-service-dars/how-the-national-data-opt-out-affects-data-released-by-nhs-digital. Published 2019. Updated 02 October 2019. Accessed 24 February 2021.
NHS Digital. NHS Data Model and Dictionary. NHS Digital. https://datadictionary.nhs.uk/. Published 2020. Updated 7 December 2020. Accessed 12 December 2020.
NHS Digital. Business Rules for Patient-level Data Extracts 2019/20, National Diabetes Audit. https://digital.nhs.uk/binaries/content/assets/website-assets/data-and-information/clinical-audits-and-registries/national_diabetes_audit_v3.docx. Published 2020. Accessed 12 December 2020.
NHS Digital. Quality and Outcomes Framework (QOF). NHS Digital. https://digital.nhs.uk/data-and-information/data-tools-and-services/data-services/general-practice-data-hub/quality-outcomes-framework-qof. Published 2020. Accessed 8 December 2020.
Holman N, Gadsby R, Dunn L, Sylvester C, Young B. How does current diabetes care compare with landmark clinical studies? Diabet Med. 2015;32(7):841-842.
Holman N, Young B. Short term mortality in people with diabetes: results from the National Diabetes Audit in England and Wales. 49th EASD (European Association for the Study of Diabetes) Annual Meeting; 23-27 September 2013, 2013; Barcelona.
Hill CJ, Cardwell CR, Maxwell AP, et al. Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit. QJM. 2013;106(10):933-942.
McKnight JA, Wild SH, Lamb MJ, et al. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32(8):1036-1050.
Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study. Lancet Diabetes Endocrinol. 2020;8(10):813-822.
Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(10):823-833.
Khunti K, Knighton P, Zaccardi F, et al. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol. 2021;9(5):293-303.